Regular paper
Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, “Eve”) and its metabolites in urine by gas chromatography — mass spectrometry and fluorescence polarization immunoassay☆

https://doi.org/10.1016/0378-4347(96)00129-6Get rights and content

Abstract

Studies are presented on the toxicological detection of the designer drug methylenedioxyethylapphetamine [MDE, rac-N-ethyl-(3,4-methylenedioxyphenyl)-propane-2-amine] in urine after a single oral dose of 140 mg of MDE by GC-MS and fluorescence polarization immunoassay (FPIA). After acid hydrolysis, extraction and acetylation MDE and its metabolites could be detected by mass chromatography with the selected ions m/z 72, 86, 114, 150, 162 and 164, followed by identification of the peaks underlying full mass spectra by computer library search. The following metabolites could be detected: unchanged MDE and 3,4-dihydroxyethylamphetamine (DHE) for 33,62 h, 3,4-methylenedioxyamphetamine (MDA) for 32–2036 h, and 4-hydroxy-3-methoxyethylamphetamine (HME) for 7 4-hydroxy-3-methoxyamphetamine (HMA), piperonul aceton, 3,4-Dihydroxyphenyl acetone and 4-hydroxy-3-methoxy-phenyl acetone could only be detected in trace amounts within the first few hours. The Abbott TDx FPIA assay amphetamine/metamphetamine II gave positive results in urine for 33--62 h. Therefore, positive immunoassay results could be confirmed by the GC-MS procedure which also allowed the differentiation of MDE and its homologues 3,4-methylenedioxymethamphetamine (MDMA) and MDA as well as other amphetamine derivatives interfering with the TDx assay. Furthermore, this GC-MS procedure allowed the simultaneous detection of most of the toxicologically relevant drugs.

References (39)

  • U. Braun et al.

    J. Pharm. Sci.

    (1980)
  • E. Gouzoulis et al.

    Biol. Psych.

    (1992)
  • D.M. Stone et al.

    Eur. J. Phamacol.

    (1987)
  • J. Brodkin et al.

    Pharmacol. Biochem. Behav.

    (1993)
  • S.F. Ali et al.

    J. Neurotoxicol. Teratol.

    (1993)
  • M. Johnson et al.

    Biochem. Pharmacol.

    (1989)
  • J.A. Henry et al.

    Lancet

    (1992)
  • A. Poklis et al.

    Forensic Sci. Int.

    (1993)
  • H.J. Helmlin et al.

    J. Chromotogr.

    (1992)
  • R.E. Michel et al.

    J. Neurosci. Methods

    (1993)
  • H.H. Maurer

    J. Chromatogr.

    (1992)
  • G.B. Baker et al.

    J. Pharmacol. Toxicol. Meth.

    (1994)
  • H.H. Maurer et al.
  • E. Gouzoulis et al.

    Neuropsychopharmacology

    (1993)
  • L. Hermle et al.

    Neuropsychopharmacology

    (1993)
  • D.E. Nichols

    J. Psychoactive Drugs

    (1986)
  • R.G. Greer et al.
  • D.L. Commins et al.

    J. Pharmacol. Exp. Ther.

    (1987)
  • T.R. Insel et al.

    J. Pharmacol. Exp. Ther.

    (1989)

    • Cited by (0)

    ☆

    Dedicated to Professor Dr. Karl Pfleger, Homburg/Saar, on the occasion of his 70th birthday. Some of these results were reported at the EUROTOX'91, Annual Meeting of the European Society of Toxicology, Maastricht, September 1--4, 1991 [1].

    View full text
    Copyright © 1996 Published by Elsevier B.V.